AMTX vs LGO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AMTX exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile operational foundation. The absence of an Altman Z-Score and negative profitability metrics—especially a -38.96% profit margin and -8.96% ROA—signal severe operational distress. Despite a 14.2% YoY revenue growth and recent positive EPS surprises, the company remains unprofitable with negative cash flow and extreme liquidity issues (current ratio of 0.07). The stock trades at a price/sales of 0.77, but this is misleading given the lack of sustainable earnings and deteriorating balance sheet. The 52-week price range of $1.22–$3.66 reflects high volatility and speculative risk.
LGO exhibits critical financial fragility, highlighted by a Piotroski F-Score of 1/9, indicating severe operational and financial deterioration. The company is facing a liquidity crisis with a Quick Ratio of 0.14 and a Current Ratio of 0.51, suggesting an inability to meet short-term obligations. While the stock trades at a discount to book value (P/B 0.59), this is likely a 'value trap' given the negative gross margins (-20.71%) and consistent revenue decline. The long-term price trajectory is catastrophic, with a 92.5% loss over five years.
Compare Another Pair
Related Comparisons
AMTX vs LGO: Head-to-Head Comparison
This page compares Aemetis, Inc. (AMTX) and Largo Inc. (LGO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.